The United Kingdom Prospective Diabetes Study (UKPDS) was the first study in which intensive blood glucose control with either insulin, sulphonylurea, or metformin, was assessed versus diet control in patients with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.